2020
DOI: 10.3389/fonc.2020.586069
|View full text |Cite
|
Sign up to set email alerts
|

Autophagy Takes Center Stage as a Possible Cancer Hallmark

Abstract: Cancer remains one of the leading causes of death worldwide, despite significant advances in cancer research and improvements in anticancer therapies. One of the major obstacles to curing cancer is the difficulty of achieving the complete annihilation of resistant cancer cells. The resistance of cancer cells may not only be due to intrinsic factors or factors acquired during the evolution of the tumor but may also be caused by chemotherapeutic treatment failure. Conversely, autophagy is a conserved cellular pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(24 citation statements)
references
References 242 publications
0
22
0
Order By: Relevance
“…Central to testosterone-vascular-inflamm-ageing triad is the early induction of amyloidosis and autophagy, which play a role in early tumor suppression in terms of the cell regulation pathways, and in their dysregulation in late stages where they act as tumor promoters [86][87][88][89][90]; this correlates to "ageing autophagy" [91][92][93][94]. Short term estrogen reduction using aromatase inhibitor in the adult Wistar male rat alters the prostatic function by reducing nitric oxide availability, inducing amyloid deposition and limiting the differentiation of basal cells through a lobe specific p63-overexpression [95].…”
Section: Testosterone-vascular-inflamm-ageing Triadmentioning
confidence: 99%
See 2 more Smart Citations
“…Central to testosterone-vascular-inflamm-ageing triad is the early induction of amyloidosis and autophagy, which play a role in early tumor suppression in terms of the cell regulation pathways, and in their dysregulation in late stages where they act as tumor promoters [86][87][88][89][90]; this correlates to "ageing autophagy" [91][92][93][94]. Short term estrogen reduction using aromatase inhibitor in the adult Wistar male rat alters the prostatic function by reducing nitric oxide availability, inducing amyloid deposition and limiting the differentiation of basal cells through a lobe specific p63-overexpression [95].…”
Section: Testosterone-vascular-inflamm-ageing Triadmentioning
confidence: 99%
“…This is the threshold point at the start of "prostate reprogramming" and the "loss" of cell function, homeostasis and regulation pathways [192][193][194][195][196][197]. It marks the beginning of a prostate stagnation tumorigenesis inflammatory microenvironment with heterogeneous events [17] including inflammation [57, [140][141][142]198], genetic aberrations [199][200][201][202][203][204][205], epigenetic dysregulation [206][207][208][209][210], autophagy dysregulation [86,87,89,90,[211][212][213][214][215][216] and lysosomal dysfunction [217][218][219][220].…”
Section: Evolutionary Tumorigenesis Microenvironmentmentioning
confidence: 99%
See 1 more Smart Citation
“…After treatment with I.1f, I.2f and II.2d at various time points (24-72 h for I.1f and 8-48 h for I.2f and II2d), the results suggested that these compounds arrested cell cycle in a time-dependent fashion (Figure 7). Apoptosis and autophagy are considered as two recognized pathways for anticancer agents due to their effects on cell survival [37,38]. In the next step, in order to investigate whether the cell death pathway is related to apoptosis or autophagy, we explored the effect of pre-treated cells with either an autophagy inhibitor (wortmannin) or a pan-caspase inhibitor (Z-VAD-FMK).…”
Section: Apoptosis and Cell Cycle Arrestmentioning
confidence: 99%
“…In cancer biology, autophagy plays a dual role in cell survival and cell death. On the one hand, autophagy inhibits the growth and development of cancer, and on the other, it allows it to survive during chemotherapy [1][2][3][4][5][6]. Cancer cells are more autophagy-dependent than normal cells, thus, targeting autophagy is a therapeutic strategy for cancer therapy [4][5][6].…”
Section: Introductionmentioning
confidence: 99%